{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:41:59Z","timestamp":1775043719964,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/bf03349159","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T02:44:52Z","timestamp":1397011492000},"page":"1208-1212","source":"Crossref","is-referenced-by-count":27,"title":["Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto\u2019s thyroiditis in Japanese population"],"prefix":"10.1007","volume":"26","author":[{"given":"M.","family":"Terauchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Fukazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"BF03349159_CR1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/edrv-10-4-537","volume":"10","author":"LJ DeGroot","year":"1989","unstructured":"DeGroot LJ, Quintans J. The causes of autoimmune thyroid disease. Endocr Rev 1989, 10: 537\u201362.","journal-title":"Endocr Rev"},{"key":"BF03349159_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2265.1992.tb01453.x","volume":"36","author":"AP Weetman","year":"1992","unstructured":"Weetman AP. Autoimmune thyroiditis: predisposition and pathogenesis. Clin Endocrinol (Oxf) 1992, 36: 307\u201323.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03349159_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1399-0039.1981.tb00700.x","volume":"17","author":"NR Farid","year":"1981","unstructured":"Farid NR, Sampson L, Moens H, Barnard M. The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens 1981, 17: 265\u20138.","journal-title":"Tissue Antigens"},{"key":"BF03349159_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1744-313X.1987.tb00374.x","volume":"14","author":"V Stenszky","year":"1987","unstructured":"Stenszky V, Balazs C, Kraszits E, et al. Association of goitrous autoimmune thyroiditis with HLA-DR3 in Eastern Hungary. J Immunogenet 1987, 14: 143\u20138.","journal-title":"J Immunogenet"},{"key":"BF03349159_CR5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-2478(85)90111-7","volume":"11","author":"C Thompson","year":"1985","unstructured":"Thompson C, Farid NR. Postpartum thyroiditis and goitrous (Hashimoto\u2019s) thyroiditis are associated with HLADR4. Immunol Letters 1985, 11: 301\u20133.","journal-title":"Immunol Letters"},{"key":"BF03349159_CR6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/jcem-73-2-236","volume":"73","author":"A Mangklabruks","year":"1991","unstructured":"Mangklabruks A, Cox N, DeGroot LJ. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphism of candidate genes. J Clin Endocrinol Metab 1991, 73: 236\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03349159_CR7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0198-8859(94)00089-9","volume":"42","author":"XL Wan","year":"1995","unstructured":"Wan XL, Kimura A, Dong RP, Honda K, Tamai H, Sasazuki T. HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto\u2019s thyroiditis. Human Immunol 1995, 42: 131\u20136.","journal-title":"Human Immunol"},{"key":"BF03349159_CR8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.1997.1710996.x","volume":"46","author":"K Kotsa","year":"1997","unstructured":"Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves\u2019 disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997, 46: 551\u20134.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03349159_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2337\/diab.47.1.128","volume":"47","author":"T Awata","year":"1998","unstructured":"Awata T, Kurihara S, Iitaka M, et al. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves\u2019 disease and Hashimoto\u2019s thyroiditis) in the Japanese population. Diabetes 1998, 47: 128\u20139.","journal-title":"Diabetes"},{"key":"BF03349159_CR10","first-page":"4130","volume":"82","author":"H Donner","year":"1997","unstructured":"Donner H, Braun J, Seidl C, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto\u2019s thyroiditis and Addison\u2019s disease. J Clin Endocrinol Metab 1997, 82: 4130\u20132.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03349159_CR11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0952-7915(96)80011-2","volume":"8","author":"EA Tivol","year":"1996","unstructured":"Tivol EA, Schweitzer AN, Sharpe AH. Costimulation and autoimmunity. Curr Opin Immunol 1996, 8: 822\u201330.","journal-title":"Curr Opin Immunol"},{"key":"BF03349159_CR12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1074-7613(00)80366-0","volume":"7","author":"CB Thompson","year":"1997","unstructured":"Thompson CB, Allison JP. The emerging role of CTLA-4 as immune attenuator. Immunity 1997, 7: 445\u201350.","journal-title":"Immunity"},{"key":"BF03349159_CR13","first-page":"41","volume":"80","author":"T Yanagawa","year":"1995","unstructured":"Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves\u2019 disease in a Caucasian population. J Clin Endocrinol Metab 1995, 80: 41\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03349159_CR14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/5.7.1075","volume":"5","author":"L Nistico","year":"1996","unstructured":"Nistico L, Buzzetti R, Pritchard LE, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996, 5: 1075\u201380.","journal-title":"Hum Mol Genet"},{"key":"BF03349159_CR15","first-page":"2740","volume":"27","author":"T Yanagawa","year":"2000","unstructured":"Yanagawa T, Gomi K, Nakao E, Inada S. CTLA-4 gene polymorphism in Japanese patients with Rheumatoid arthritis. J Rheumatol 2000, 27: 2740\u20132.","journal-title":"J Rheumatol"},{"key":"BF03349159_CR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0165-5728(98)00119-2","volume":"88","author":"D Huang","year":"1998","unstructured":"Huang D, Liu L, Noren K, et al. Genetic association of Ctla-4 to myasthenia gravis with thymoma. J. Neuroimmunol 1998, 88: 92\u20138.","journal-title":"J. Neuroimmunol"},{"key":"BF03349159_CR17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1365-2265.1998.00579.x","volume":"49","author":"EH Kemp","year":"1998","unstructured":"Kemp EH, Ajjan RA, Husebye ES, et al. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison\u2019s disease in English patients. Clin Endocrinol (Oxf) 1998, 49: 609\u201313.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03349159_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(99)00251-8","volume":"171","author":"T Fukazawa","year":"1999","unstructured":"Fukazawa T, Yanagawa T, Kikuchi S, et al. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. J Neurol Sci 1999, 171: 49\u201355.","journal-title":"J Neurol Sci"},{"key":"BF03349159_CR19","first-page":"4018","volume":"19","author":"MH Polymeropoulos","year":"1991","unstructured":"Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the human CTLA4 gene. Nucleic Acids Res. 1991, 19: 4018.","journal-title":"Nucleic Acids Res."},{"key":"BF03349159_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","volume":"19","author":"B Woolf","year":"1955","unstructured":"Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955, 19: 251\u20133.","journal-title":"Ann Hum Genet"},{"key":"BF03349159_CR21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diab.46.6.1069","volume":"46","author":"D Owerbach","year":"1997","unstructured":"Owerbach D, Naya FJ, Tsai MJ, Allander SV, Powell DR, Gabby KH. Analysis of candidate genes for susceptibility to type 1 diabetes. A case-control and family-association study of genes on chromosome 2q31\u201335. Diabetes 1997, 46: 1069\u201374.","journal-title":"Diabetes"},{"key":"BF03349159_CR22","first-page":"101","volume":"61","author":"WA MacKenzie","year":"1987","unstructured":"MacKenzie WA, Davies TF. An intrathyroidal T cell clone specifically cytotoxic for human thyroid cells. Immunology 1987, 61: 101\u20133.","journal-title":"Immunology"},{"key":"BF03349159_CR23","first-page":"2398","volume":"84","author":"JM Heward","year":"1999","unstructured":"Heward JM, Allahabadia A, Armitage M, et al. The development of Graves\u2019 disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 1999, 84: 2398\u2013401.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03349159_CR24","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"165","author":"T Kouki","year":"2000","unstructured":"Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves\u2019 disease. J Immunol 2000, 165: 6606\u201311.","journal-title":"J Immunol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03349159\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:46:53Z","timestamp":1558522013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03349159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["BF03349159"],"URL":"https:\/\/doi.org\/10.1007\/bf03349159","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}